Japanese Journal of Clinical Pharmacology and Therapeutics
Published by Japanese Society of Clinical Pharmacology and Therapeutics (Journal Finder)
ISSN : 0388-1601 eISSN : 1882-8272
Abbreviation : Jpn. J. Clin. Pharmacol. Ther.
Aims & Scope
The Japanese Journal of Clinical Pharmacology and Therapeutics（the Journal）is a journal published by the Japanese Society of Clinical Pharmacology and Therapeutics（the Society).
The Journal publishes papers on all aspects of interdisciplinary research concerning human pharmacological treatment, with the goal of contributing to the advancement of the fields of clinical pharmacology and therapeutics not only within Japan but globally.
The areas of study from which the Journal awaits submission of original papers are as follows：clinical studies concerning the development of new medicines or treatments intended for human use and the ethics thereof；translational research；research on individualized pharmacological treatment including pharmacogenomics；research on interactions with medicine, environmental factors, and nutrition relating to variability in drug responses；pharmacokinetics and pharmacodynamics research；pharmacometrics research；pharmacoepidemiology research；research on medical economics relating to pharmacological treatment；regulatory science research；topics of the education of clinical pharmacology and therapeutics；and any other related topic that authors consider to be within the purpose and goal of the Journal.
The target audience for the Journal comprises medical doctors, pharmacists, nurses, clinical research coordinators（CRCs), and others involved in pharmacological therapy, who are members of the Society.
Moreover, the Journal offers a platform for vigorous discussion of political issues of medicines and review articles related to the above fields.
View Aims & ScopeMetrics & Ranking
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.112 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q4 |
h-index
| Year | Value |
|---|---|
| 2024 | 9 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 28228 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 5 |
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Absorption and Excretion of Tranexamic Acid following Intravenous, Intramuscular and Oral Administrations in Healthy Volunteers
Citation: 40
Authors: Mitsuji, Hideo, Chieko, Takeshi
-
Phase I Study of Levofloxacin, (S)-(-)-Ofloxacin.
Citation: 34
Authors: Mitsuyoshi, Toshihiko, Mitsutaka, Osamu, Hideo
-
Phase I Clinical Study of MCI-186(Edaravone, 3-methyl-1-phenyl-2-pyrazolin-5-one) in Healthy Volunteers: Safety and Pharmacokinetics of Single and Multiple Administrations.
Citation: 32
Authors: Hisao, Shigenori, Minae, Mitsukuni, Yasuo, Osamu, Chizuko, Masahiko
-
VOLUNTARY INHALATION OF VOLATILE ANESTHETICS AND ORGANIC SOLVENTS BY MONKEYS
Citation: 28
Authors: Tomoji, Saburo, Katsuzo, Hiroko
-
Influence of 7-day hospitalization for phase i study on the biochemical laboratory tests of healthy volunteers.
Citation: 20
Authors: Mitsutaka, Satoru, Toshihiko, Mitsuyoshi
-
Pharmacokinetics and Pharmacodynamics of Eltrombopag in Healthy Japanese Males
Citation: 18
Authors: Yuri, Naoki, Shigeru, Toshiyasu
-
A Pharmacokinetic Study of MCI-186, a Novel Drug for Cerebrovascular Disease in Elderly and Young Health Subjects.
Citation: 17
Authors: Shinichi, Yuji, Mitsutomo, Shinano, Mitsukuni, Kei, Masato, Takayuki, Masao
